EcoR1 Capital is a biotech-focused investment advisory firm that partners with entrepreneurs to advance therapeutic innovation and create new medicines. The company evaluates and invests in biotech companies with the potential to transform patient outcomes, leveraging scientific and strategic expertise to foster breakthroughs in untreated diseases. EcoR1 Capital is based in San Francisco, California.
Recent Transactions involving EcoR1 Capital
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics |
Spyre Therapeutics |
Aeglea BioTherapeutics |
EcoR1 CapitalFairmount Funds ManagementVenrock Healthcare Capital PartnersCommodore CapitalPerceptive AdvisorsRTW InvestmentsCormorant Asset ManagementDriehaus Capital ManagementSurveyor CapitalWellington Management CompanyUndisclosed Institutional InvestorsFidelity Management and ResearchRA Capital ManagementDeepTrack Capital |
Biotechnology Research |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →